Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

EJHaem·2024
Same author

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.

Blood advances·2023
Same author

Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms.

Research and practice in thrombosis and haemostasis·2023
Same author

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.

Blood advances·2023
Same author

Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2022

Related Experiment Video

Updated: Jul 4, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Platelet function testing in uraemic patients.

Shir-Jing Ho1, Rosalie Gemmell, Timothy A Brighton

  • 1SEALS, Department of Haematology, St George Hospital, Gray St, Kogarah, NSW 2217, Australia. shir-jing.ho@sesiahs.health.nsw.gov.au

Hematology (Amsterdam, Netherlands)
|June 7, 2008
PubMed
Summary

Platelet dysfunction in chronic renal failure (CRF) causes bleeding. This study found skin bleeding time (SBT) is not reliably predicted by kidney function tests or newer platelet assays.

More Related Videos

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Experiment Videos

Last Updated: Jul 4, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Area of Science:

  • Nephrology
  • Hematology
  • Clinical Pathology

Background:

  • Chronic renal failure (CRF) is linked to bleeding disorders, primarily due to platelet dysfunction affecting platelet interactions.
  • The skin bleeding time (SBT) is a known predictor of bleeding in uremic patients, but its accuracy and reproducibility are limited.
  • Newer rapid platelet function assays exist but haven't been thoroughly evaluated in CRF patients.

Purpose of the Study:

  • To assess the predictive value of kidney function tests and novel in vitro platelet assays for skin bleeding time (SBT) in patients with renal impairment.
  • To investigate the correlation between calculated glomerular filtration rate (GFR) and SBT in patients with acute and chronic renal failure.

Main Methods:

  • A prospective cohort study involving patients with acute and chronic renal impairment.
  • Analysis of laboratory parameters including GFR, SBT, whole blood platelet aggregation (WBPA), platelet function analyzer (PFA-100), thromboelastograph (TEG), and cone platelet analyzer (CPA).

Main Results:

  • Calculated GFR showed a weak correlation with SBT (r² = 0.1564), while serum creatinine and urea levels demonstrated even poorer correlation.
  • The PFA-100 assay was found to be a poor predictor of SBT.
  • Abnormalities in WBPA and CPA were observed across various SBT ranges, with no clear predictive pattern identified for SBT.

Conclusions:

  • Serum creatinine and calculated GFR do not reliably predict prolonged SBT in patients with renal impairment.
  • This pilot study did not identify a definitive in vitro alternative assay to accurately replicate SBT in this patient population.